 Bennett Jones James D. BeebyPartner • Co-Head of Corporate Department Vancouver beebyj@bennettjones.com Education Warwick University (UK), LLB (Hons), 1992 University of British Columbia, LLB, 1996 Bar Admissions British Columbia, 1997 James Beeby provides clients experienced and innovative advice with their most challenging M&A, corporate finance and private funds formation mandates. Overview James Beeby co-leads the firm's Corporate Department and advises publicly-listed companies, institutional investors, fund sponsors and private enterprises on matters relating to corporate finance, mergers and acquisitions, private equity and venture capital. James has extensive experience advising on public offerings of debt and equity securities, public takeover bids, plans of arrangement, cross-border acquisitions, corporate governance, related party transactions, private acquisitions and divestitures, joint ventures, venture capital investments and private fund formation. James’ practice includes clients in a variety of industries including mining, life sciences, finance and technology. James regularly writes and speaks on matters relating to securities law and private equity and is a member of Practical Law's Corporate M&A and Securities Advisory Board for Canada and of the Foundation for Natural Resources and Energy Law. Corporate Finance • A strategic investor in its US$25-million secured convertible debt financing of a technology company. • First Majestic Silver Corp. in it's $100-million secondary offering of common shares. • Canadian counsel to Jefferies LLC, Oppenheimer & Co and Bloom Burton Securities, as underwriters for a public offering of US$38,990,000 of common shares of Essa Pharma Inc. • First Mining, in its $28.75-million bought deal offering, issuing 57,500,000 units of the Company. • First Majestic Silver Corp. in the $78-million bought deal offering of common shares. • First Majestic Silver Corp., in an at-the-market equity distribution agreement with BMO Capital Markets Corp. and TD Securities (USA) LLC for the sale of up to US$150-million of common shares. • First Mining Gold Corp., in an equity distribution agreement with Cantor Fitzgerald Canada Corporation with respect to an at-the-market offering of up to $15 million of common shares. • Emerald Health Therapeutics, Inc., in an at-the-market equity offering for the sale of up to $39 million of common shares pursuant to an equity distribution agreement with GMP Securities L.P. • Emerald Health Therapeutics Inc. (TSXV: EMH), with the sale of 10,235,000 units of Emerald for gross proceeds of $13,817,250 pursuant to an underwriting agreement between Emerald and Dundee Capital Partners. • First Majestic Silver Corp., with a US$150-million brokered private placement of convertible debentures on a bought deal basis. • Kaminak Gold Corporation, with its $21-million bought deal private placement. • ShaMaran Petroleum Corp., as Canadian counsel, with its $75,421,500 rights offering. • CohBar, Inc., a U.S. biotechnology company, as Canadian counsel, with its US$11,250,000 initial public offering and concurrent listing on the TSX Venture Exchange. • Emerald Health Therapeutics Inc., with its reverse takeover and listing on the TSX Venture Exchange. M & A • Alkane Resources in its A$559-million merger with Mandalay Resources • BioLife Solutions, as Canadian counsel, in its acquisition of PanTHERA CryoSolutions • First Majestic Silver Corp. in its US$970-million acquisition of Gatos Silver • Briacell Therapeutics Corp., in the spin-out of BriaPro Therapeutics Corp. • PFS Genomics Inc. in the US$30.6-million sale of a 90% interest to 1300342 B.C. Ltd., a wholly-owned subsidiary of Exact Sciences RDX LLC. • Emerald Health Therapeutics, Inc., in the $79.9-million sale of its interest in the Pure Sunfarms joint venture to Village Farms International Inc. • Corex Gold Corporation, in its $50-million combination with Minera Alamos Inc. • Emerald Health acquires Québec-based Licensed Producer Agro-Biotech. • First Majestic Silver Corp., with its US$320-million acquisition of Primero Mining and new stream agreement at San Dimas Mine. • IWG Technologies Inc., with the acquisition of IWG by 1096777 B.C. Ltd., a private British Columbia corporation by way of plan of arrangement under the Business Corporations Act. • First Mining Finance Corp., with its acquisition of Gold Canyon Resources Inc. and PC Gold Inc., both reporting issuers listed on the TSX Venture Exchange. • First Majestic Silver Corp., in the acquisition of SilverCrest Mines Inc., a silver-mining company listed on the Toronto Stock Exchange. • First Mining Finance Corp., in the acquisition of Coastal Gold Mining Corp., a company listed on the TSX Venture Exchange. Private Equity • AVAC Ltd. as manager and general partner in connection with the formation of Carrot Ventures Fund I., L.P. a venture capital fund forming new agricultural technology companies with total initial committed capital of $15-million. • The advisory board of a Canadian venture capital fund with committed capital over $100,000,000 in the removal of the Fund's original general partner and the admission of a successor general partner to the Fund and its parallel fund. • The Province of British Columbia, with the formation of the BC Tech Fund Limited Partnership. • Vanedge Capital, in the formation of its second venture capital fund, Vanedge Capital II Limited Partnership, which secured approximately $100 million in commitments in its first closing in January 2016. Corporate Commercial • Briacell Therapeutics Corp., in the spin-out of BriaPro Therapeutics Corp. • Emerald Health Therapeutics Inc. (TSXV: EMH), with the formation of a joint venture with Village Farms International Inc. for large-scale, high-quality, low-cost cannabis production. |